UK Life Science Strategy Urges Adoption Of Accelerated Access Review, As Govt Prepares Response

 
• By Ian Schofield

A set of proposals in the recently published Life Sciences Industrial Strategy, aimed at improving the way new products are identified and made available under the NHS, reiterates ideas contained in the 2016 Accelerated Access Review. The government says it will respond to the review shortly.

Benefit & Cost
Value assessments are part of the industry's wish-list in UK life science strategy

More from Market Access

More from Pink Sheet